stella
beta
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes — Stella
Recruiting
Back to Acute Myeloid Leukemia trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(8 sites)
United States
City of Hope Medical Center, Duarte, California
University of California Irvine, Irvine, California
University of Kansas Medical Center Research Institute, Inc., Kansas City, Kansas
Alliance for Multispecialty Research, LLC, Merriam, Kansas
Roswell Park Comprehensive Cancer Center, Buffalo, New York
Show all 8 locations
View full record on ClinicalTrials.gov